Using next-generation RNA sequencing to examine ischemic changes induced by cold blood cardioplegia on the human left ventricular myocardium transcriptome

Anesthesiology

Volumn 122, Issue 3, 2015, Pages 537-550

  Muehlschlegel, Jochen D ^a   Christodoulou, Danos C ^a   McKean, David ^a   Gorham, Joshua ^a   Mazaika, Erica ^a   Heydarpour, Mahyar ^a   Lee, Grace ^a   DePalma, Steven R ^a   Perry, Tjorvi E ^b   Fox, Amanda A ^c   Shernan, Stanton K ^a   Seidman, Christine E ^d   Aranki, Sary F ^d   Seidman, Jon G ^a   Body, Simon C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; COMPLEMENT; CYTOKINE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

AORTA VALVE REPLACEMENT; APOPTOSIS; ARTICLE; BINDING SITE; CARDIOPLEGIA; COLD EXPOSURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENETIC ANALYSIS; GENOMICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEMOGLOBIN ALPHA1 GENE; HEMOGLOBIN BETA GENE; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOPATHOLOGY; INFLAMMATION; INTELECTIN 1 GENE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PROTEOGLYCAN 4 GENE; RNA SEQUENCE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR GENE; TRANSCRIPTOMICS; UPREGULATION; VIRUS ONCOGENE; AGED; CARDIAC MUSCLE; COLD; FEMALE; GENETICS; HEART ARREST; HEART VENTRICLE; MALE; MYOCARDIAL ISCHEMIA; PATHOLOGY; PROCEDURES; SEQUENCE ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLD TEMPERATURE; FEMALE; HEART ARREST, INDUCED; HEART VENTRICLES; HUMANS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84924336817     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000582     Document Type: Article

References (42)

1. Bretschneider HJ, Hübner G, Knoll D, Lohr B, Nordbeck H, Spieckermann PG: Myocardial resistance and tolerance to ischemia: Physiological and biochemical basis. J Cardiovasc Surg (Torino) 1975; 16:241-60
2. Walsh MC, Bourcier T, Takahashi K, Shi L, Busche MN, Rother RP, Solomon SD, Ezekowitz RA, Stahl GL: Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 2005; 175:541-6
3. Feng J, Bianchi C, Sandmeyer JL, Li J, Sellke FW: Molecular indices of apoptosis after intermittent blood and crystalloid cardioplegia. Circulation 2005; 112(9 suppl):I184-9
4. Etievent JP, Chocron S, Toubin G, Taberlet C, Alwan K, Clement F, Cordier A, Schipman N, Kantelip JP: Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg 1995; 59:1192-4
5. Muehlschlegel JD, Perry TE, Liu KY, Nascimben L, Fox AA, Collard CD, Avery EG, Aranki SF, D'Ambra MN, Shernan SK, Body SC; CABG Genomics Investigators: Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J 2009; 30:1574-83
6. Mohammed AA, Agnihotri AK, van Kimmenade RR, Martinez-Rumayor A, Green SM, Quiroz R, Januzzi JL Jr: Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation 2009; 120:843-50
7. Matte GS, del Nido PJ: History and use of del Nido cardioplegia solution at Boston Children's Hospital. J Extra Corpor Technol 2012; 44:98-103
8. Trapnell C, Pachter L, Salzberg SL: TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25:1105-11
9. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L: Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012; 7:562-78
10. Langmead B, Trapnell C, Pop M, Salzberg SL: Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10:R25
11. Xing Y, Yu T, Wu YN, Roy M, Kim J, Lee C: An expectation-maximization algorithm for probabilistic reconstructions of full-length isoforms from splice graphs. Nucleic Acids Res 2006; 34:3150-60
12. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y: RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 2008; 18:1509-17
13. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological) 1995; 57: 289-300
14. Kel A, Voss N, Jauregui R, Kel-Margoulis O, Wingender E: Beyond microarrays: Find key transcription factors controlling signal transduction pathways. BMC Bioinformatics 2006; 7(suppl 2):S13
15. Kel A, Voss N, Valeev T, Stegmaier P, Kel-Margoulis O, Wingender E: ExPlain: Finding upstream drug targets in disease gene regulatory networks. SAR QSAR Environ Res 2008; 19:481-94
16. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, Meinhardt T, Prüss M, Reuter I, Schacherer F: TRANSFAC: An integrated system for gene expression regulation. Nucleic Acids Res 2000; 28:316-9
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545-50
18. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction: Third universal definition of myocardial infarction. Circulation 2012; 126:2020-35
19. Du W, Wang YC, Hong J, Su WY, Lin YW, Lu R, Xiong H, Fang JY: STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species. J Cell Physiol 2012; 227:2421-9
20. Chen G, Wang H, Xie S, Ma J, Wang G: STAT1 negatively regulates hepatocellular carcinoma cell proliferation. Oncol Rep 2013; 29:2303-10
21. Lee HG, Minematsu H, Kim KO, Celil Aydemir AB, Shin MJ, Nizami SA, Chung KJ, Hsu AC, Jacobs CR, Lee FY: Actin and ERK1/2-CEBPβ signaling mediates phagocytosis-induced innate immune response of osteoprogenitor cells. Biomaterials 2011; 32:9197-206
22. Benderdour M, Fahmi H, Beaudet F, Fernandes JC, Shi Q: Nuclear receptor retinoid-related orphan receptor α1 modulates the metabolic activity of human osteoblasts. J Cell Biochem 2011; 112:2160-9
23. Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y: Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 2010; 393:668-72
24. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y: Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011; 408:339-43
25. Tan BK, Adya R, Farhatullah S, Chen J, Lehnert H, Randeva HS: Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes 2010; 59:3023-31
26. Mattu HS, Randeva HS: Role of adipokines in cardiovascular disease. J Endocrinol 2013; 216:T17-36
27. Kataoka Y, Shibata R, Ohashi K, Kambara T, Enomoto T, Uemura Y, Ogura Y, Yuasa D, Matsuo K, Nagata T, Oba T, Yasukawa H, Numaguchi Y, Sone T, Murohara T, Ouchi N: Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. J Am Coll Cardiol 2014; 63:2722-33
28. Hoggard N, Cruickshank M, Moar KM, Bashir S, Mayer CD: Using gene expression to predict differences in the secretome of human omental vs. subcutaneous adipose tissue. Obesity (Silver Spring) 2012; 20:1158-67
29. Wendel HP, Heller W, Michel J, Mayer G, Ochsenfahrt C, Graeter U, Schulze J, Hoffmeister HM, Hoffmeister HE: Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage. J Thorac Cardiovasc Surg 1995; 109:1164-72
30. Buerke M, Pruefer D, Sankat D, Carter JM, Buerke U, Russ M, Schlitt A, Friedrich I, Börgermann J, Vahl CF, Werdan K: Effects of aprotinin on gene expression and protein synthesis after ischemia and reperfusion in rats. Circulation 2007; 116(11 suppl):I121-6
31. Ikegawa S, Sano M, Koshizuka Y, Nakamura Y: Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes. Cytogenet Cell Genet 2000; 90:291-7
32. Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF: Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet 2000; 24:184-7
33. Kalra N, Kumar V: c-Fos is a mediator of the c-myc-induced apoptotic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway. J Biol Chem 2004; 279:25313-9
34. Pan Z, Sun X, Shan H, Wang N, Wang J, Ren J, Feng S, Xie L, Lu C, Yuan Y, Zhang Y, Wang Y, Lu Y, Yang B: MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. Circulation 2012; 126:840-50
35. Lukk M, Kapushesky M, Nikkilä J, Parkinson H, Goncalves A, Huber W, Ukkonen E, Brazma A: A global map of human gene expression. Nat Biotechnol 2010; 28:322-4
36. Arab S, Konstantinov IE, Boscarino C, Cukerman E, Mori A, Li J, Liu PP, Redington AN, Coles JG: Early gene expression profiles during intraoperative myocardial ischemia-reperfusion in cardiac surgery. J Thorac Cardiovasc Surg 2007; 134:74-81, 81.e1-2
37. He Y, Hua Y, Liu W, Hu H, Keep RF, Xi G: Effects of cerebral ischemia on neuronal hemoglobin. J Cereb Blood Flow Metab 2009; 29:596-605
38. Verrier ED, Shernan SK, Taylor KM, Van de Werf F, Newman MF, Chen JC, Carrier M, Haverich A, Malloy KJ, Adams PX, Todaro TG, Mojcik CF, Rollins SA, Levy JH; PRIMOCABG Investigators: Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: A randomized trial. JAMA 2004; 291:2319-27
39. Arumugam TV, Magnus T, Woodruff TM, Proctor LM, Shiels IA, Taylor SM: Complement mediators in ischemia-reperfusion injury. Clin Chim Acta 2006; 374:33-45
40. Kortekaas KA, van der Pol P, Lindeman JH, Baan CC, van Kooten C, Klautz RJ: No prominent role for terminal complement activation in the early myocardial reperfusion phase following cardiac surgery. Eur J Cardiothorac Surg 2012; 41:e117-25
41. Charlagorla P, Liu J, Patel M, Rushbrook JI, Zhang M: Loss of plasma membrane integrity, complement response and formation of reactive oxygen species during early myocardial ischemia/reperfusion. Mol Immunol 2013; 56: 507-12
42. Tárnok A, Hambsch J, Emmrich F, Sack U, van Son J, Bellinghausen W, Borte M, Schneider P: Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass. Pediatr Cardiol 1999; 20:113-25